Lay opinion vs evidence: Gluten Check

Lay opinion often holds that a 'Gluten Check' DNA test can reliably diagnose gluten sensitivity or intolerance. The evidence, however, is more nuanced. Celiac disease is a well-defined autoimmune condition with validated serological and biopsy markers. Non-celiac gluten sensitivity (NCGS) remains a controversial diagnosis of exclusion, lacking any established biomarker. Commercial DNA tests typically analyze HLA-DQ2/DQ8 variants, which are necessary but not sufficient for celiac disease. A positive result indicates increased genetic risk, not disease; a negative result does not rule out celiac disease. For NCGS, no genetic test has been clinically validated. Most direct-to-consumer gluten tests combine such markers with general dietary advice, but their predictive value for actual gluten-related symptoms is unproven. The evidence level is 'mixed' to 'unclear': mechanistic plausibility exists, but clinical utility as a diagnostic tool is absent. Safety note: If celiac disease is suspected, medical evaluation (blood tests, endoscopy) should be performed before starting a gluten-free diet, as dietary changes can mask diagnostic markers.